US Endoscopy announces full market release of the Respa™ O2 delivery bite block

Mentor, Ohio — October 22, 2013 — US Endoscopy, a world leader in endoscopy device design and manufacturing, is proud to announce the release of the Respa™ O2 delivery bite block. The Respa™ bite block is purpose-built to hold the nasal cannula in place during upper GI procedures.

During procedures, patients may switch from breathing through their nose to breathing through their mouth. If this occurs, the clinician may need to relocate the oxygen cannula to the mouth or bite block. When the cannula is repositioned, it can interfere with the procedure by falling out of place or getting in the way of the endoscope.

“The challenges many clinicians face during these procedures can extend procedure time and create additional costs for the facility,” says Tony Siracusa, Vice President and General Manager of US Endoscopy. “Unlike others on the market, the Respa™ bite block is specifically designed to house the nasal cannula, helping to eliminate frustrations, and ensure delivery of oxygen to patients is uninterrupted.”

About US Endoscopy
US Endoscopy, a subsidiary of STERIS Corporation, is a world leader in endoscopy device design and manufacturing, serving the U.S. and international gastrointestinal endoscopy markets.  By listening and delivering solutions in the field of endoscopy, our unique lines of devices provide better, more enhanced product options for GI clinicians.  A significant and growing portion of sales are from endoscopic devices created by the company's new product development team with the guidance and direction of luminary physicians and nurses worldwide. 

About STERIS Corporation
The mission of STERIS Corporation is to provide a healthier today and safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. The Company has approximately 6,000 dedicated employees around the world working together to supply a broad array of solutions by offering a combination of equipment, consumables and services to healthcare, pharmaceutical, industrial and government Customers. The Company is listed on the New York Stock Exchange under the symbol STE. For more information, visit


US Endoscopy press releases can be found in the News section of .  To arrange interviews concerning US Endoscopy products and services, please Contact Us.